Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
about
Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neuronsIron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.Determination of salsolinol, norsalsolinol, and twenty-one biogenic amines using micellar electrokinetic capillary chromatography-electrochemical detection.Chiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: observation of complex stereoisomerismParkinson's disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein.Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.A guide to neurotoxic animal models of Parkinson's diseaseComputational Modeling of Inclusion Complexes of β-Cyclodextrin with enantiomers of Salsolinol, N-Methyl-Salsolinol, and 1-Benzyl-Tetrahydroisoquinoline.Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.Salsolinol Damaged Neuroblastoma SH-SY5Y Cells Induce Proliferation of Human Monocyte THP-1 Cells Through the mTOR Pathway in a Co-culture System.Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection.Analysis of drug-endogenous human metabolite similarities in terms of their maximum common substructures.Oxidative modification of human ceruloplasmin induced by a catechol neurotoxin, salsolinolSalsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.Adaptive Modifications of Maternal Hypothalamic-Pituitary-Adrenal Axis Activity during Lactation and Salsolinol as a New Player in this Phenomenon.
P2860
Q28469183-0CFA42F0-557A-44E9-B740-187A5819C5AFQ33337387-1A34BB9A-37F7-4197-B03E-0034EA364EE4Q33941251-612F0640-87F6-4384-B1C5-0E3F054B58DFQ34930863-5415B8E6-170B-49F6-8A56-6D388B553F1EQ35032823-86C6FF3A-4365-4500-9D04-4148D48D9DDFQ35252890-E452D514-A0E1-484C-971B-9F958F04E002Q35603488-4E8FF89D-C30A-437F-B021-B818D712D777Q37035624-DE401166-A879-41F5-9874-9A92F5654543Q38834545-9C7DE396-CA75-4B9A-BC3A-D37FCF3F330EQ38899693-565CA47C-CA15-4A68-8662-EA4DAB98705EQ39635730-B048A113-BD5A-46D6-AA3D-267A044000ACQ41959283-F81A214C-48CB-4706-AF48-701A3D24326AQ42197717-3215768E-CEE9-4528-A69C-82BB3AE1D27DQ48004001-F38C93AC-AB5A-4107-925C-77EEF9AFDFBFQ55005786-A636B0B9-4433-4209-A93B-89C84DC8C6FB
P2860
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dopamine-derived endogenous N-methyl-
@nl
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@ast
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@en
type
label
Dopamine-derived endogenous N-methyl-
@nl
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@ast
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@en
prefLabel
Dopamine-derived endogenous N-methyl-
@nl
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@ast
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@en
P2093
P1476
Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
@en
P2093
Makoto Naoi
Wakako Maruyama
Yukihiro Akao
P304
P356
10.1016/S0892-0362(02)00211-8
P577
2002-09-01T00:00:00Z